ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 269599 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 269599; 2) Community: the network communities that were significantly associated with the response to NSC 269599; 3) Molecule: the relationships between components within communities and NSC 269599; 4) MDR: the compounds that were significantly associated with the NSC 269599.

NSC Compound Enrichment Correlation
NSC 639976 Cyclopentanone, 2-[2-methyl-2-[4-(2-methylpropyl)- phenyl]ethylidene]-5-[(4-morpholinyl)methyl]-, hydrochloride 0.0181211508101519 0.43454999
NSC 640083 Null 0.0181211508101519 0.43215024
NSC 645431 1H-Benz[g]indol-5-ol, 2-phenyl 0.0181211508101519 0.24914416
NSC 656208 Null 0.0181211508101519 0.40507205
NSC 65921 Fluorene, 9-bromo-2,4,7-trichloro- 0.0181211508101519 0.37859978
NSC 671311 Null 0.0181211508101519 0.17089876
NSC 672472 Null 0.0181211508101519 0.33250701
NSC 673421 Null 0.0181211508101519 0.42709616
NSC 681229 Boronic acid, [1-[[2-amino-3-(1-naphthalenyl)- 1-oxopropyl]amino]-3-methylbutyl]-, L-(S)-, hydrochloride 0.0181211508101519 0.42588669
NSC 681637 Camptothecin Derivative 0.0181211508101519 0.0048009883
Total:115  Current:60    [First] [Prev] [Next] [Last]